BioCentury
ARTICLE | Company News

Ashni, BioNexus Genomics Inc. deal

January 31, 2000 8:00 AM UTC

Ashni acquired BioNexus in a stock transaction under which BioNexus shareholders will own 50 percent of Ashni. Ashni will use BioNexus' BIOprinting process, which uses a combination of genomic and pro...